The global market for Immunology Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The immune system is an assembly of structures and processes inside the body to protect against possibly damaging foreign bodies and diseases. It identifies various threats like bacteria, viruses, and parasites and distinguishes them from body"s healthy tissues. When the immune system weakness and lose the capability to detect and destroy the abnormal cells or body attacks and damages its tissues lead to diseases like cancer and autoimmune diseases. Immunotherapy is a process which includes the treatment by inducing, enhancing or suppressing an immune system to fight against the diseases.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Immunology Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunology Drug.

The Immunology Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immunology Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Immunology Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Immunology Drug Market Report

Report Metric	Details
Report Name	Immunology Drug Market
CAGR	5%
Segment by Type	Monoclonal Antibodies (mAb) Antibody Drug Conjugates Immunosuppressive medication Others
Segment by Application	Hospitals Clinics Cancer Research Centers and Institutes
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Abbott Laboratories, Active Biotech, Eli Lilly and Company, Autoimmune Inc., Pfizer, GlaxoSmithKline plc, Seattle Genetics, Genentech, F. Hoffmann-La Roche Ltd., Eisai Co., Bayer AG, Sanofi Aventis LLC.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Immunology Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Immunology Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Immunology Drug Market report?

Ans: The main players in the Immunology Drug Market are Abbott Laboratories, Active Biotech, Eli Lilly and Company, Autoimmune Inc., Pfizer, GlaxoSmithKline plc, Seattle Genetics, Genentech, F. Hoffmann-La Roche Ltd., Eisai Co., Bayer AG, Sanofi Aventis LLC.

What are the Application segmentation covered in the Immunology Drug Market report?

Ans: The Applications covered in the Immunology Drug Market report are Hospitals, Clinics, Cancer Research Centers and Institutes

What are the Type segmentation covered in the Immunology Drug Market report?

Ans: The Types covered in the Immunology Drug Market report are Monoclonal Antibodies (mAb), Antibody Drug Conjugates, Immunosuppressive medication, Others

1 Immunology Drug Market Overview

1.1 Product Definition

1.2 Immunology Drug by Type

1.2.1 Global Immunology Drug Market Value Comparison by Type (2024 VS 2031)

1.2.2 Monoclonal Antibodies (mAb)

1.2.3 Antibody Drug Conjugates

1.2.4 Immunosuppressive medication

1.2.5 Others

1.3 Immunology Drug by Application

1.3.1 Global Immunology Drug Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Cancer Research Centers and Institutes

1.4 Global Immunology Drug Market Size Estimates and Forecasts

1.4.1 Global Immunology Drug Revenue 2020-2031

1.4.2 Global Immunology Drug Sales 2020-2031

1.4.3 Global Immunology Drug Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Immunology Drug Market Competition by Manufacturers

2.1 Global Immunology Drug Sales Market Share by Manufacturers (2020-2025)

2.2 Global Immunology Drug Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Immunology Drug Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Immunology Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Immunology Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Immunology Drug, Product Type & Application

2.7 Global Key Manufacturers of Immunology Drug, Date of Enter into This Industry

2.8 Global Immunology Drug Market Competitive Situation and Trends

2.8.1 Global Immunology Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Immunology Drug Players Market Share by Revenue

2.8.3 Global Immunology Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Immunology Drug Market Scenario by Region

3.1 Global Immunology Drug Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Immunology Drug Sales by Region: 2020-2031

3.2.1 Global Immunology Drug Sales by Region: 2020-2025

3.2.2 Global Immunology Drug Sales by Region: 2026-2031

3.3 Global Immunology Drug Revenue by Region: 2020-2031

3.3.1 Global Immunology Drug Revenue by Region: 2020-2025

3.3.2 Global Immunology Drug Revenue by Region: 2026-2031

3.4 North America Immunology Drug Market Facts & Figures by Country

3.4.1 North America Immunology Drug Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Immunology Drug Sales by Country (2020-2031)

3.4.3 North America Immunology Drug Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Immunology Drug Market Facts & Figures by Country

3.5.1 Europe Immunology Drug Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Immunology Drug Sales by Country (2020-2031)

3.5.3 Europe Immunology Drug Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Immunology Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Immunology Drug Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Immunology Drug Sales by Region (2020-2031)

3.6.3 Asia Pacific Immunology Drug Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Immunology Drug Market Facts & Figures by Country

3.7.1 Latin America Immunology Drug Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Immunology Drug Sales by Country (2020-2031)

3.7.3 Latin America Immunology Drug Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Immunology Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Immunology Drug Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Immunology Drug Sales by Country (2020-2031)

3.8.3 Middle East and Africa Immunology Drug Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Immunology Drug Sales by Type (2020-2031)

4.1.1 Global Immunology Drug Sales by Type (2020-2025)

4.1.2 Global Immunology Drug Sales by Type (2026-2031)

4.1.3 Global Immunology Drug Sales Market Share by Type (2020-2031)

4.2 Global Immunology Drug Revenue by Type (2020-2031)

4.2.1 Global Immunology Drug Revenue by Type (2020-2025)

4.2.2 Global Immunology Drug Revenue by Type (2026-2031)

4.2.3 Global Immunology Drug Revenue Market Share by Type (2020-2031)

4.3 Global Immunology Drug Price by Type (2020-2031)

5 Segment by Application

5.1 Global Immunology Drug Sales by Application (2020-2031)

5.1.1 Global Immunology Drug Sales by Application (2020-2025)

5.1.2 Global Immunology Drug Sales by Application (2026-2031)

5.1.3 Global Immunology Drug Sales Market Share by Application (2020-2031)

5.2 Global Immunology Drug Revenue by Application (2020-2031)

5.2.1 Global Immunology Drug Revenue by Application (2020-2025)

5.2.2 Global Immunology Drug Revenue by Application (2026-2031)

5.2.3 Global Immunology Drug Revenue Market Share by Application (2020-2031)

5.3 Global Immunology Drug Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Abbott Laboratories

6.1.1 Abbott Laboratories Company Information

6.1.2 Abbott Laboratories Description and Business Overview

6.1.3 Abbott Laboratories Immunology Drug Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Abbott Laboratories Immunology Drug Product Portfolio

6.1.5 Abbott Laboratories Recent Developments/Updates

6.2 Active Biotech

6.2.1 Active Biotech Company Information

6.2.2 Active Biotech Description and Business Overview

6.2.3 Active Biotech Immunology Drug Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Active Biotech Immunology Drug Product Portfolio

6.2.5 Active Biotech Recent Developments/Updates

6.3 Eli Lilly and Company

6.3.1 Eli Lilly and Company Company Information

6.3.2 Eli Lilly and Company Description and Business Overview

6.3.3 Eli Lilly and Company Immunology Drug Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Eli Lilly and Company Immunology Drug Product Portfolio

6.3.5 Eli Lilly and Company Recent Developments/Updates

6.4 Autoimmune Inc.

6.4.1 Autoimmune Inc. Company Information

6.4.2 Autoimmune Inc. Description and Business Overview

6.4.3 Autoimmune Inc. Immunology Drug Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Autoimmune Inc. Immunology Drug Product Portfolio

6.4.5 Autoimmune Inc. Recent Developments/Updates

6.5 Pfizer

6.5.1 Pfizer Company Information

6.5.2 Pfizer Description and Business Overview

6.5.3 Pfizer Immunology Drug Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Pfizer Immunology Drug Product Portfolio

6.5.5 Pfizer Recent Developments/Updates

6.6 GlaxoSmithKline plc

6.6.1 GlaxoSmithKline plc Company Information

6.6.2 GlaxoSmithKline plc Description and Business Overview

6.6.3 GlaxoSmithKline plc Immunology Drug Sales, Revenue and Gross Margin (2020-2025)

6.6.4 GlaxoSmithKline plc Immunology Drug Product Portfolio

6.6.5 GlaxoSmithKline plc Recent Developments/Updates

6.7 Seattle Genetics

6.7.1 Seattle Genetics Company Information

6.7.2 Seattle Genetics Description and Business Overview

6.7.3 Seattle Genetics Immunology Drug Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Seattle Genetics Immunology Drug Product Portfolio

6.7.5 Seattle Genetics Recent Developments/Updates

6.8 Genentech

6.8.1 Genentech Company Information

6.8.2 Genentech Description and Business Overview

6.8.3 Genentech Immunology Drug Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Genentech Immunology Drug Product Portfolio

6.8.5 Genentech Recent Developments/Updates

6.9 F. Hoffmann-La Roche Ltd.

6.9.1 F. Hoffmann-La Roche Ltd. Company Information

6.9.2 F. Hoffmann-La Roche Ltd. Description and Business Overview

6.9.3 F. Hoffmann-La Roche Ltd. Immunology Drug Sales, Revenue and Gross Margin (2020-2025)

6.9.4 F. Hoffmann-La Roche Ltd. Immunology Drug Product Portfolio

6.9.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates

6.10 Eisai Co.

6.10.1 Eisai Co. Company Information

6.10.2 Eisai Co. Description and Business Overview

6.10.3 Eisai Co. Immunology Drug Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Eisai Co. Immunology Drug Product Portfolio

6.10.5 Eisai Co. Recent Developments/Updates

6.11 Bayer AG

6.11.1 Bayer AG Company Information

6.11.2 Bayer AG Description and Business Overview

6.11.3 Bayer AG Immunology Drug Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Bayer AG Immunology Drug Product Portfolio

6.11.5 Bayer AG Recent Developments/Updates

6.12 Sanofi Aventis LLC.

6.12.1 Sanofi Aventis LLC. Company Information

6.12.2 Sanofi Aventis LLC. Description and Business Overview

6.12.3 Sanofi Aventis LLC. Immunology Drug Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Sanofi Aventis LLC. Immunology Drug Product Portfolio

6.12.5 Sanofi Aventis LLC. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Immunology Drug Industry Chain Analysis

7.2 Immunology Drug Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Immunology Drug Production Mode & Process Analysis

7.4 Immunology Drug Sales and Marketing

7.4.1 Immunology Drug Sales Channels

7.4.2 Immunology Drug Distributors

7.5 Immunology Drug Customer Analysis

8 Immunology Drug Market Dynamics

8.1 Immunology Drug Industry Trends

8.2 Immunology Drug Market Drivers

8.3 Immunology Drug Market Challenges

8.4 Immunology Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Abbott Laboratories

Active Biotech

Eli Lilly and Company

F Hoffmann La Roche Ltd

Eisai Co Ltd

Bayer

Sanofi-Aventis LLC

List of Tables

Table 1. Global Immunology Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Immunology Drug Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Immunology Drug Market Competitive Situation by Manufacturers in 2024

Table 4. Global Immunology Drug Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Immunology Drug Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Immunology Drug Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Immunology Drug Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Immunology Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Immunology Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Immunology Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Immunology Drug, Product Type & Application

Table 12. Global Key Manufacturers of Immunology Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Immunology Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunology Drug as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Immunology Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Immunology Drug Sales by Region (2020-2025) & (K Units)

Table 18. Global Immunology Drug Sales Market Share by Region (2020-2025)

Table 19. Global Immunology Drug Sales by Region (2026-2031) & (K Units)

Table 20. Global Immunology Drug Sales Market Share by Region (2026-2031)

Table 21. Global Immunology Drug Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Immunology Drug Revenue Market Share by Region (2020-2025)

Table 23. Global Immunology Drug Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Immunology Drug Revenue Market Share by Region (2026-2031)

Table 25. North America Immunology Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Immunology Drug Sales by Country (2020-2025) & (K Units)

Table 27. North America Immunology Drug Sales by Country (2026-2031) & (K Units)

Table 28. North America Immunology Drug Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Immunology Drug Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Immunology Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Immunology Drug Sales by Country (2020-2025) & (K Units)

Table 32. Europe Immunology Drug Sales by Country (2026-2031) & (K Units)

Table 33. Europe Immunology Drug Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Immunology Drug Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Immunology Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Immunology Drug Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Immunology Drug Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Immunology Drug Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Immunology Drug Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Immunology Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Immunology Drug Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Immunology Drug Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Immunology Drug Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Immunology Drug Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Immunology Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Immunology Drug Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Immunology Drug Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Immunology Drug Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Immunology Drug Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Immunology Drug Sales (K Units) by Type (2020-2025)

Table 51. Global Immunology Drug Sales (K Units) by Type (2026-2031)

Table 52. Global Immunology Drug Sales Market Share by Type (2020-2025)

Table 53. Global Immunology Drug Sales Market Share by Type (2026-2031)

Table 54. Global Immunology Drug Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Immunology Drug Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Immunology Drug Revenue Market Share by Type (2020-2025)

Table 57. Global Immunology Drug Revenue Market Share by Type (2026-2031)

Table 58. Global Immunology Drug Price (USD/Unit) by Type (2020-2025)

Table 59. Global Immunology Drug Price (USD/Unit) by Type (2026-2031)

Table 60. Global Immunology Drug Sales (K Units) by Application (2020-2025)

Table 61. Global Immunology Drug Sales (K Units) by Application (2026-2031)

Table 62. Global Immunology Drug Sales Market Share by Application (2020-2025)

Table 63. Global Immunology Drug Sales Market Share by Application (2026-2031)

Table 64. Global Immunology Drug Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Immunology Drug Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Immunology Drug Revenue Market Share by Application (2020-2025)

Table 67. Global Immunology Drug Revenue Market Share by Application (2026-2031)

Table 68. Global Immunology Drug Price (USD/Unit) by Application (2020-2025)

Table 69. Global Immunology Drug Price (USD/Unit) by Application (2026-2031)

Table 70. Abbott Laboratories Company Information

Table 71. Abbott Laboratories Description and Business Overview

Table 72. Abbott Laboratories Immunology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Abbott Laboratories Immunology Drug Product

Table 74. Abbott Laboratories Recent Developments/Updates

Table 75. Active Biotech Company Information

Table 76. Active Biotech Description and Business Overview

Table 77. Active Biotech Immunology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Active Biotech Immunology Drug Product

Table 79. Active Biotech Recent Developments/Updates

Table 80. Eli Lilly and Company Company Information

Table 81. Eli Lilly and Company Description and Business Overview

Table 82. Eli Lilly and Company Immunology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Eli Lilly and Company Immunology Drug Product

Table 84. Eli Lilly and Company Recent Developments/Updates

Table 85. Autoimmune Inc. Company Information

Table 86. Autoimmune Inc. Description and Business Overview

Table 87. Autoimmune Inc. Immunology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Autoimmune Inc. Immunology Drug Product

Table 89. Autoimmune Inc. Recent Developments/Updates

Table 90. Pfizer Company Information

Table 91. Pfizer Description and Business Overview

Table 92. Pfizer Immunology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Pfizer Immunology Drug Product

Table 94. Pfizer Recent Developments/Updates

Table 95. GlaxoSmithKline plc Company Information

Table 96. GlaxoSmithKline plc Description and Business Overview

Table 97. GlaxoSmithKline plc Immunology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. GlaxoSmithKline plc Immunology Drug Product

Table 99. GlaxoSmithKline plc Recent Developments/Updates

Table 100. Seattle Genetics Company Information

Table 101. Seattle Genetics Description and Business Overview

Table 102. Seattle Genetics Immunology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Seattle Genetics Immunology Drug Product

Table 104. Seattle Genetics Recent Developments/Updates

Table 105. Genentech Company Information

Table 106. Genentech Description and Business Overview

Table 107. Genentech Immunology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Genentech Immunology Drug Product

Table 109. Genentech Recent Developments/Updates

Table 110. F. Hoffmann-La Roche Ltd. Company Information

Table 111. F. Hoffmann-La Roche Ltd. Description and Business Overview

Table 112. F. Hoffmann-La Roche Ltd. Immunology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. F. Hoffmann-La Roche Ltd. Immunology Drug Product

Table 114. F. Hoffmann-La Roche Ltd. Recent Developments/Updates

Table 115. Eisai Co. Company Information

Table 116. Eisai Co. Description and Business Overview

Table 117. Eisai Co. Immunology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Eisai Co. Immunology Drug Product

Table 119. Eisai Co. Recent Developments/Updates

Table 120. Bayer AG Company Information

Table 121. Bayer AG Description and Business Overview

Table 122. Bayer AG Immunology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Bayer AG Immunology Drug Product

Table 124. Bayer AG Recent Developments/Updates

Table 125. Sanofi Aventis LLC. Company Information

Table 126. Sanofi Aventis LLC. Description and Business Overview

Table 127. Sanofi Aventis LLC. Immunology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Sanofi Aventis LLC. Immunology Drug Product

Table 129. Sanofi Aventis LLC. Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Immunology Drug Distributors List

Table 133. Immunology Drug Customers List

Table 134. Immunology Drug Market Trends

Table 135. Immunology Drug Market Drivers

Table 136. Immunology Drug Market Challenges

Table 137. Immunology Drug Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Product Picture of Immunology Drug

Figure 2. Global Immunology Drug Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Immunology Drug Market Share by Type: 2024 & 2031

Figure 4. Monoclonal Antibodies (mAb) Product Picture

Figure 5. Antibody Drug Conjugates Product Picture

Figure 6. Immunosuppressive medication Product Picture

Figure 7. Others Product Picture

Figure 8. Global Immunology Drug Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Immunology Drug Market Share by Application: 2024 & 2031

Figure 10. Hospitals

Figure 11. Clinics

Figure 12. Cancer Research Centers and Institutes

Figure 13. Global Immunology Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Immunology Drug Market Size (2020-2031) & (US$ Million)

Figure 15. Global Immunology Drug Sales (2020-2031) & (K Units)

Figure 16. Global Immunology Drug Average Price (USD/Unit) & (2020-2031)

Figure 17. Immunology Drug Report Years Considered

Figure 18. Immunology Drug Sales Share by Manufacturers in 2024

Figure 19. Global Immunology Drug Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Immunology Drug Players: Market Share by Revenue in Immunology Drug in 2024

Figure 21. Immunology Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Immunology Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Immunology Drug Sales Market Share by Country (2020-2031)

Figure 24. North America Immunology Drug Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Immunology Drug Sales Market Share by Country (2020-2031)

Figure 28. Europe Immunology Drug Revenue Market Share by Country (2020-2031)

Figure 29. Germany Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Immunology Drug Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Immunology Drug Revenue Market Share by Region (2020-2031)

Figure 36. China Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Immunology Drug Sales Market Share by Country (2020-2031)

Figure 47. Latin America Immunology Drug Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Immunology Drug Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Immunology Drug Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. U.A.E Immunology Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Immunology Drug by Type (2020-2031)

Figure 57. Global Revenue Market Share of Immunology Drug by Type (2020-2031)

Figure 58. Global Immunology Drug Price (USD/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Immunology Drug by Application (2020-2031)

Figure 60. Global Revenue Market Share of Immunology Drug by Application (2020-2031)

Figure 61. Global Immunology Drug Price (USD/Unit) by Application (2020-2031)

Figure 62. Immunology Drug Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions